miltefosine has been researched along with antimony in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (30.30) | 29.6817 |
| 2010's | 16 (48.48) | 24.3611 |
| 2020's | 7 (21.21) | 2.80 |
| Authors | Studies |
|---|---|
| Murray , HW | 1 |
| Sundar, S | 1 |
| Arana, B; Diaz, A; Rizzo, N | 1 |
| Murray, HW | 1 |
| Marty, P; Rosenthal, E | 1 |
| Boelaert, M; Diap, G; Gerstl, S; Guerin, PJ; Meheus, F; Van der Stuyft, P; Vanlerberghe, V | 1 |
| Mumtaz, N; Rahman, SB; ul Bari, A | 1 |
| Minodier, P; Parola, P | 1 |
| Blanc, P; Garnier, JM; Minodier, P; Noël, G; Retornaz, K; Uters, M | 1 |
| Beck, JC; Berman, J; Davidson, C; Mings, S; Ondo, AL; Shanler, SD | 1 |
| Duncan, RC; Kumar, D; Nakhasi, HL; Salotra, P; Singh, R | 1 |
| Ampuero, J; Carvalho, EM; Guimarães, LH; Machado, PR; Penna, G; Rocha, AT; Schriefer, A; Sousa, RS; Talhari, A; Villasboas, L | 1 |
| Bavchvarov, BI; Campillo, M; Castanys, S; Gamarro, F; López-Martín, C; Martínez-García, M; Pérez-Victoria, JM; Torrecillas, IR | 1 |
| De Doncker, S; Decuypere, S; Dujardin, JC; Maes, L; Rijal, S; Vanaerschot, M | 1 |
| Leprohon, P; Moreira, W; Ouellette, M | 1 |
| Chatterjee, M; Ghosh, S; Pakrashi, S; Roy, D; Sarkar, A; Sen, S | 1 |
| Boulet, G; Cos, P; Delputte, P; Dujardin, JC; Hendrickx, S; Lachaud, L; Maes, L; Mondelaers, A; Rijal, S | 1 |
| Diaz-Toro, Y; Fernández, OL; Gomez, MA; Muvdi, S; Ovalle, C; Rodríguez, I; Saravia, NG; Valderrama, L | 1 |
| Chatterjee, M; Singh, N; Sundar, S | 1 |
| Coelho, AC; Cotrim, PC; Oliveira, JC; Reimão, JQ; Trinconi, CT; Uliana, SR | 1 |
| Blackburn, G; Carter, KC; Coombs, GH; Cotton, JA; Downing, T; Dujardin, JC; Freeman, TM; Illingworth, CJ; Imamura, H; Khanal, B; Lonchamp, J; Rijal, S; Sanders, M; Shaw, CD | 1 |
| Bifeld, E; Clos, J; Höhn, K; Tejera Nevado, P | 1 |
| Bresson, E; Fernandez-Prada, C; Leprohon, P; Ouellette, M; Plourde, M; Roy, G; Sharma, M | 1 |
| Aguado, B; Camacho, E; Castanys, S; Corvo, L; Dujardin, JC; Gamarro, F; García-Hernández, R; Imamura, H; Rastrojo, A; Requena, JM; Vargas, P | 1 |
| Caljon, G; Cos, P; Delputte, P; Gielis, JF; Hendrickx, S; Maes, L; Van Bockstal, L; Van den Kerkhof, M | 1 |
| Carregal, VM; Demicheli, C; Frézard, F; Fujiwara, RT; Islam, A; Lanza, JS; Rivas, L; Souza, DM | 1 |
| Barral, A; Barral-Netto, M; Boaventura, V; Carvalho, EM; Corte, TWF; Guimarães, LH; Lago, T; Machado, PRL; Penna, G; Prates, FVO; Schriefer, A | 1 |
| Bhattacharyya, M; Bodhale, NP; Pai, K; Saha, B; Sundar, S | 1 |
| Ali, N; Ashraf, S; den Boer, M; Fernhout, J; Grobusch, MP; Kämink, S; Khan, SJ; Masih, B; Pylypenko, T; Ritmeijer, K; Ullah, A | 1 |
| Alves, F; Brack, M; Dahal, P; Guerin, PJ; Halleux, CM; Hawryszkiewycz, A; Maguire, BJ; Ngu, R; Olliaro, PL; Rashan, S; Singh-Phulgenda, S; Stepniewska, K | 1 |
| Murta, SMF; Santi, AMM; Santos, IFM; Silva, PA | 1 |
| Alves, LL; Carvalho, JP; Cota, G; Freire, ML; Silva, SN; Souza, CSA | 1 |
| de Groote, R; de Muylder, G; Domagalska, MA; Dujardin, JC; Maes, I; Monsieurs, P; Negreira, GH; Van den Broeck, F; Van Giel, D | 1 |
8 review(s) available for miltefosine and antimony
| Article | Year |
|---|---|
Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches.
Topics: Adult; Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Child; Humans; Leishmania donovani; Leishmaniasis, Visceral; Mice; Paromomycin; Phosphorylcholine; Treatment Outcome | 2000 |
Chemotherapy of cutaneous leishmaniasis: a review.
Topics: Antifungal Agents; Antimony; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Ointments; Organometallic Compounds; Phosphorylcholine | 2001 |
Progress in the treatment of a neglected infectious disease: visceral leishmaniasis.
Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Clinical Trials as Topic; Deoxycholic Acid; Drug Combinations; Drug Costs; Humans; Leishmaniasis, Visceral; Paromomycin; Phosphatidylcholines; Phosphatidylglycerols; Phosphorylcholine; Practice Guidelines as Topic | 2004 |
[Visceral leishmaniases].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Brazil; Child, Preschool; Dogs; Ethiopia; Europe; Humans; Incidence; India; Infant; Infant, Newborn; Leishmaniasis, Visceral; Phosphorylcholine; Prevalence; Time Factors; Zoonoses | 2004 |
Cutaneous leishmaniasis treatment.
Topics: Administration, Cutaneous; Administration, Oral; Aminoquinolines; Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Humans; Imiquimod; Injections, Intralesional; Injections, Intramuscular; Leishmaniasis, Cutaneous; Paromomycin; Pentamidine; Phosphorylcholine | 2007 |
[Treatment of visceral leishmaniasis in children].
Topics: Amphotericin B; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine | 2007 |
Serious adverse events following treatment of visceral leishmaniasis: A systematic review and meta-analysis.
Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Deoxycholic Acid; Drug Combinations; Humans; Leishmaniasis, Visceral; Phosphorylcholine | 2021 |
The cure rate after different treatments for mucosal leishmaniasis in the Americas: A systematic review.
Topics: Antimony; Humans; Leishmaniasis, Mucocutaneous; Pentoxifylline | 2022 |
3 trial(s) available for miltefosine and antimony
| Article | Year |
|---|---|
Miltefosine in cutaneous leishmaniasis.
Topics: Adult; Antimony; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine | 2007 |
Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial.
Topics: Abdominal Pain; Administration, Oral; Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Female; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Middle Aged; Nausea; Phosphorylcholine; Prevalence; Treatment Outcome; Vomiting; Young Adult | 2010 |
A Double-blind, Randomized Trial to Evaluate Miltefosine and Topical Granulocyte Macrophage Colony-stimulating Factor in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil.
Topics: Antimony; Antiprotozoal Agents; Brazil; Granulocyte-Macrophage Colony-Stimulating Factor; Granulocytes; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Macrophage Colony-Stimulating Factor; Phosphorylcholine; Treatment Outcome | 2021 |
22 other study(ies) available for miltefosine and antimony
| Article | Year |
|---|---|
Drug resistance in Indian visceral leishmaniasis.
Topics: Aminoquinolines; Amphotericin B; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Drug Resistance; Geography; History, 20th Century; History, 21st Century; Humans; India; Leishmaniasis, Visceral; Paromomycin; Pentamidine; Phosphorylcholine; Treatment Outcome | 2001 |
Drug policy for visceral leishmaniasis: a cost-effectiveness analysis.
Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Cost-Benefit Analysis; Decision Trees; Deoxycholic Acid; Drug Combinations; Endemic Diseases; Health Care Costs; Humans; Leishmaniasis, Visceral; Phosphorylcholine; Treatment Outcome | 2007 |
Cutaneous leishmaniasis with boggy induration and simultaneous mucosal disease.
Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Biopsy; Bolivia; Drug Therapy, Combination; Female; Humans; Leishmaniasis, Cutaneous; Middle Aged; Phosphorylcholine; Travel; Treatment Outcome | 2009 |
Overexpression of histone H2A modulates drug susceptibility in Leishmania parasites.
Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Drug Resistance; Histones; Humans; India; Leishmania donovani; Mitogen-Activated Protein Kinase 1; Oligonucleotide Array Sequence Analysis; Phosphorylcholine; Protozoan Proteins | 2010 |
Sitamaquine overcomes ABC-mediated resistance to miltefosine and antimony in Leishmania.
Topics: Aminoquinolines; Antimony; Antiprotozoal Agents; ATP-Binding Cassette Transporters; Drug Resistance, Bacterial; Ketoconazole; Leishmania tropica; Leishmaniasis; Phosphorylcholine; Protein Binding | 2011 |
Antimonial resistance in Leishmania donovani is associated with increased in vivo parasite burden.
Topics: Animals; Antimony; Antiprotozoal Agents; Drug Resistance; India; Leishmania donovani; Liver; Mice; Mice, Inbred BALB C; Phosphorylcholine; Spleen | 2011 |
Tolerance to drug-induced cell death favours the acquisition of multidrug resistance in Leishmania.
Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Apoptosis; Cell Death; Drug Resistance, Multiple; Drug Tolerance; Leishmania infantum; Methotrexate; Paromomycin; Phosphorylcholine; Reactive Oxygen Species | 2011 |
Leishmania strains causing self-healing cutaneous leishmaniasis have greater susceptibility towards oxidative stress.
Topics: Antimony; Free Radicals; Humans; Leishmania major; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Macrophages; Nitric Oxide; Oxidative Stress; Phosphorylcholine; Superoxide Dismutase | 2012 |
Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of Leishmania donovani and L. infantum.
Topics: Animals; Antimony; Antiprotozoal Agents; Drug Resistance; Female; Humans; Leishmania donovani; Macrophages; Mice; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine | 2014 |
Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia.
Topics: Adolescent; Adult; Aged; Antimony; Child; Child, Preschool; Cohort Studies; Colombia; Drug Resistance; Humans; Infant; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phosphorylcholine; Randomized Controlled Trials as Topic; Young Adult | 2014 |
The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India.
Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Drug Resistance; Glutamate-Cysteine Ligase; Humans; India; Leishmania donovani; Leishmaniasis, Visceral; Membrane Transport Proteins; Mutation; Phosphorylcholine; Protozoan Proteins; Sulfhydryl Compounds | 2014 |
Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging.
Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Humans; India; Leishmania infantum; Leishmaniasis, Visceral; Luciferases; Parasite Load; Phosphorylcholine; Recombinant Proteins | 2015 |
In vitro selection of miltefosine resistance in promastigotes of Leishmania donovani from Nepal: genomic and metabolomic characterization.
Topics: Animals; Antimony; Antiprotozoal Agents; Drug Resistance; Female; Leishmania donovani; Leishmaniasis, Visceral; Lipid Metabolism; Membrane Transport Proteins; Mice; Mice, Inbred BALB C; Mutation; Nepal; Parasitic Sensitivity Tests; Phosphorylcholine | 2016 |
A Telomeric Cluster of Antimony Resistance Genes on Chromosome 34 of Leishmania infantum.
Topics: Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Cadmium; Cloning, Molecular; Copper; Drosophila Proteins; Drug Resistance; Exosomes; Gene Expression; Heat-Shock Proteins; High-Throughput Nucleotide Sequencing; Leishmania infantum; Life Cycle Stages; Multigene Family; Phosphorylcholine; Protozoan Proteins; Telomere | 2016 |
High-throughput Cos-Seq screen with intracellular Leishmania infantum for the discovery of novel drug-resistance mechanisms.
Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Cosmids; CRISPR-Cas Systems; Drug Resistance; Gene Library; High-Throughput Nucleotide Sequencing; Leishmania infantum; Leishmaniasis; Life Cycle Stages; Macrophages; Phosphorylcholine | 2018 |
Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs.
Topics: Antimony; Antiprotozoal Agents; Drug Resistance, Multiple; Genomics; Leishmania donovani; Leishmania infantum; Leishmania major; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Paromomycin; Phenotype; Phosphorylcholine; Transcriptome | 2018 |
Impact of primary mouse macrophage cell types on Leishmania infection and in vitro drug susceptibility.
Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Cells, Cultured; Drug Resistance; Female; Interleukin-6; Leishmania infantum; Leishmaniasis; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nitric Oxide; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2018 |
Combination oral therapy against Leishmania amazonensis infection in BALB/c mice using nanoassemblies made from amphiphilic antimony(V) complex incorporating miltefosine.
Topics: Administration, Oral; Animals; Antimony; Antiprotozoal Agents; Disease Models, Animal; Female; Leishmania mexicana; Leishmaniasis, Cutaneous; Mice, Inbred BALB C; Nanoparticles; Phosphorylcholine | 2019 |
The drug resistance mechanisms in Leishmania donovani are independent of immunosuppression.
Topics: Amphotericin B; Animals; Antimony; Cytokines; Drug Resistance; Immunosuppression Therapy; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mice; Mice, Inbred BALB C; Phosphorylcholine; Protozoan Proteins | 2021 |
Effectiveness of miltefosine in cutaneous leishmaniasis caused by Leishmania tropica in Pakistan after antimonial treatment failure or contraindications to first line therapy-A retrospective analysis.
Topics: Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Child; Female; Humans; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Middle Aged; Patient Outcome Assessment; Phosphorylcholine; Retrospective Studies; Treatment Failure; Young Adult | 2021 |
Downregulation of FeSOD-A expression in Leishmania infantum alters trivalent antimony and miltefosine susceptibility.
Topics: Antimony; Antiprotozoal Agents; Down-Regulation; Leishmania infantum; Mutation; Oxidative Stress; Phosphorylcholine; Superoxide Dismutase | 2021 |
The adaptive roles of aneuploidy and polyclonality in Leishmania in response to environmental stress.
Topics: Aneuploidy; Antimony; Chromosomes; Humans; Leishmania | 2023 |